at 04:20 |
|
|
Pfizer Inc. today announced longer-term follow-up results from the Phase 2 single-arm PHAROS clinical trial evaluating the efficacy and safety of BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for patients with BRAF V600E-mutant...
|
at 03:20 |
|
|
Merck , known as MSD outside of the United States and Canada, today announced overall survival (OS) results from the final analysis of the Phase 3 KEYNOTE-811 trial evaluating KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with...
|
at 03:10 |
|
|
Johnson & Johnson today announced updated results from the Phase 3 MARIPOSA-2 study which showed RYBREVANT® (amivantamab-vmjw) combined with chemotherapy led to consistent benefit across post-progression outcomes in adult patients with previously...
|
13 sep 2024 |
|
|
Masimo , a leading global medical innovator, today announced a partnership with Google to develop a new reference platform for original equipment manufacturers (OEMs) building Wear OS by Googletm smartwatches. By incorporating Masimo's breakthrough...
|
13 sep 2024 |
|
|
Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Extreme Networks, Inc. ("Extreme Networks" or the "Company") ....
|
13 sep 2024 |
|
|
The Wing Luke Museum today announced that Joël Barraquiel Tan is stepping down as executive director. This decision comes after careful reflection.Barraquiel Tan joined the Wing Luke Museum as executive director in April 2022, just as the...
|
|
|